M.s Ph.D. Suma Gopinathan - 28 Feb 2026 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
SVP, Discovery
Signature
/s/ Suma Gopinathan, M.S, Ph.D.
Issuer symbol
LXRX
Transactions as of
28 Feb 2026
Net transactions value
-$35,777
Form type
4
Filing time
03 Mar 2026, 07:18:43 UTC
Previous filing
17 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gopinathan Suma SVP, Discovery 2445 TECHNOLOGY FOREST BLVD, 11TH FLOOR, THE WOODLANDS /s/ Suma Gopinathan, M.S, Ph.D. 03 Mar 2026 0002071581

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +14,000 +19% 88,520 28 Feb 2026 Direct F1
transaction LXRX Common Stock Options Exercise +20,310 +23% 108,830 28 Feb 2026 Direct F1
transaction LXRX Common Stock Options Exercise +65,640 +60% 174,470 28 Feb 2026 Direct F1
transaction LXRX Common Stock Tax liability $35,777 -24,338 -14% $1.47 150,132 28 Feb 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -14,000 -100% 0 28 Feb 2026 Common Stock 14,000 Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -20,310 -50% 20,310 28 Feb 2026 Common Stock 20,310 Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -65,640 -33% 131,280 28 Feb 2026 Common Stock 65,640 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.